XERS - Xeris Biopharma Holdings Inc Dividends

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: AMRX SUPN KNSA ALKS INDV LNTH BHC HRMY TEVA VTRS

| Held by: VTI IWM VXF IWO SCHA XPH VTWO FESM FYC IWC

Scroll to Statements

Index	RUT	P/E	117.40	EPS (ttm)	0.07	Insider Own	4.42%	Shs Outstand	172.56M	Perf Week	10.65%
Market Cap	1.33B	Forward P/E	21.07	EPS next Y	0.36	Insider Trans	-2.77%	Shs Float	165.54M	Perf Month	23.43%
Enterprise Value	1.47B	PEG	-	EPS next Q	0.01	Inst Own	61.71%	Short Float	7.74%	Perf Quarter	38.06%
Income	12.01M	P/S	4.22	EPS this Y	4425.82%	Inst Trans	3.04%	Short Ratio	7.74	Perf Half Y	5.63%
Sales	314.85M	P/B	101.99	EPS next Y	151.48%	ROA	3.39%	Short Interest	12.81M	Perf YTD	-2.04%
Book/sh	0.08	P/C	11.88	EPS next 5Y	-	ROE	-	52W High	10.08 -23.71%	Perf Year	62.24%
Cash/sh	0.65	P/FCF	27.94	EPS past 3/5Y	- -	ROIC	4.53%	52W Low	4.52 70.13%	Perf 3Y	194.64%
Dividend Est.	-	EV/EBITDA	30.30	Sales past 3/5Y	38.33% 70.20%	Gross Margin	82.45%	Volatility	4.16% 3.84%	Perf 5Y	59.88%
Dividend TTM	-	EV/Sales	4.68	EPS Y/Y TTM	123.74%	Oper. Margin	11.40%	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.50	Sales Y/Y TTM	41.47%	Profit Margin	3.81%	RSI (14)	77.13	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	120.83%	SMA20	14.91%	Beta	0.67	Target Price	11.29
Payout	0.00%	Debt/Eq	19.87	Sales Q/Q	38.27%	SMA50	20.07%	Rel Volume	3.81	Prev Close	7.40
Employees	435	LT Debt/Eq	19.39	Earnings	May 07 BMO	SMA200	9.39%	Avg Volume	1.66M	Price	7.69
IPO	Jun 21, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	470.37% 3.28%	Trades		Volume	6,306,062	Change	3.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)